Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Amylyx Pharmaceuticals
company
About
Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.
- 101 - 250
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $135M
- Industries
- Biotechnology,Medical,Neuroscience,Pharmaceutical
- Founded date
- Jan 1, 2014
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain. The company features a drug designed to prevent nerve cell death and degeneration.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$135M
Amylyx Pharmaceuticals has raised a total of
$135M
in funding over 2 rounds. Their latest funding was raised on
Jul 20, 2021 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 20, 2021 | Series C | $135M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Amylyx Pharmaceuticals is funded by 1 investors.
Polaris Founders Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Polaris Founders Capital
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
